MiNK Therapeutics, Inc. (INKT) Form 10-Q Quarterly Reports
MiNK Therapeutics, Inc. (INKT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INKT
CIK: 1840229
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerGregory Stamm
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-11 | 4 | 0001193125-26-421529 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001973379-26-000350 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 | 0001193125-26-379575 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 | 0001193125-26-379524 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 | 0001193125-26-379522 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 | 0001193125-26-379518 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 | 0001193125-26-379513 | View SEC Doc Filr Page |
| S-8 | 2026-08-13 | — | S-8 | 0001193125-26-349328 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349309 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-347907 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-17 | 8-K | 0001193125-26-278642 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260084 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-03-02 | 4 | 0001193125-26-253474 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-03-02 | 4 | 0001193125-26-253470 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-03-02 | 4 | 0001193125-26-253468 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-03-02 | 4 | 0001193125-26-253466 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-03-02 | 4 | 0001193125-26-253461 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-226804 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001193125-26-225369 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-197583 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-17 | DEF 14A | 0001193125-26-197577 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2025-09-23 | 4 | 0001193125-26-197482 | View SEC Doc Filr Page |
| 3 | 2026-04-09 | 2026-03-13 | 3 | 0001193125-26-149642 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001193125-26-134813 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-31 | 8-K | 0001193125-26-133346 | View SEC Doc Filr Page |